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This study compares the results of percutaneous trans-
luminal coronary angioplasty in a group of 132 patients
(group A) with fixed atherosclerotic narrowing (no spon-
taneous or ergonovine-provoked spasm) and in a group
of 97 patients (group B) with dynamic coronary stenosis
(spasm superimposed on the stenosis). All these patients
underwent complete follow-up angiography. The rate of
restenosis (defined as a loss of 50% of the initial gain)
was significantly higher in patients in group B (dynamic
coronary stenosis) than in group A (fixednarrowing) (35
Percutaneous transluminal coronary angioplasty is a new
approach to the treatment of atherosclerotic coronary ste-
nosis. The efficacy of this technique is well established but
restenosis can occur in 20 to 28% of cases and could limit
the long-term benefit of the procedure. Recent follow-up
data from the Percutaneous Transluminal Coronary Angio-
plasty (PTCA) Registry of the National Heart, Lung, and
Blood Institute (1) shows a restenosis value of 33.6% among
557 patients with angiographic follow-up. However, some
studies (2,3) have shown that the results of coronary an-
gioplasty were less satisfactory in patients with Prinzmetal's
variant angina than in other patients. Therefore, the purpose
of this study was to compare the results obtained with coro-
nary angioplasty in patients with dynamic coronary stenosis
and in those with fixed atherosclerotic narrowing.
Methods
Patients. From December 1981 to September 1985, 522
patients with significant coronary artery narrowing (2:: 60%)
underwent percutaneous transluminal coronary angioplasty
in our institution: 478 (83%) had a primary successful result,
defined as an improvement of at least 20% in the angio-
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versus 22%, P < 0.05). Despite treatment with a calcium
antagonist, coronary artery spasm persisted in 44% of
the patients in group B and was detected for the first
time in 15% of the patients in group A.
Thus, in patients with dynamic coronary stenosis, the
results of coronary angioplasty were less satisfactory than
in patients with fixed narrowing, and in both groups
coronary artery spasm was frequently (64%) superim-
posed on the restenosis.
(J Am Coil CardioI1986;8:504-8)
graphic appearance of the stenosis without complications.
Our protocol included a systematic restudy with coronary
angiography 6 to 8 months after the procedure, and 275
patients completed this angiographic follow-up. Among these
patients, 229 were selected because all (except those with
spontaneous spasm) had undergone a provocative test with
ergonovine at the time of the first coronary angiographic
study.
These patients were classified into two groups: Group A
included 132 patients with a fixed atherosclerotic coronary
narrowing, that is, nonmodified by ergonovine. Group B
included 97 patients with dynamic coronary stenosis, char-
acterized by spontaneous (n = 14) or provoked (n = 83)
coronary artery spasm superimposed on atherosclerotic ste-
nosis.
Definition of spasm. Coronary spasm was defined as a
transient (reversible with intracoronary injection of isosor-
bide dinitrate) total occlusion of the vessel at the site of the
narrowing that had been dilated. The two groups had equiv-
alent severity of atherosclerotic narrowing (70 ± 13% in
group A, 72 ± 13% in group B). The patients in both
groups were discharged on a daily regimen of dipyridamole
(150 mg) and nifedipine (40 to 60 mg). All of these patients
(symptomatic or asymptomatic) underwent a second coro-
nary angiographic study 6 to 8 months later and the pro-
cedure was completed by an ergometrine test in 210 patients.
Follow-up angiography. During follow-up angiography
the preceding definition of spasm was applied to the patients
0735-1097/86/$3.50
lACC Vol. 8. No. 3
September 1986:504- 8
BERTRAND ET AL
ANGIOPLASTY IN DYNAMIC OR FIXED CORONARY STENOSIS
505
Table 1. Clinical and Angiographic Data in 229 Patients
F = female; LAD = left anterior descending coronary artery; LCx
= left circumflex coronary artery; M = male; PICA = percutaneous
transluminal coronary angioplasty; RCA = right coronary artery.
Results
Patient characteristics (Table 1). The 113 men and 19
women in Group A had a mean age of 53 ± 13 years. Thi s
with restenosis (defined as a loss of 50% of the initial gain
achieved at angioplasty ). In patients without restenosis ,
coronary spasm was defined as either a total transient oc-
clusion of the vessel or the appearance of a transient sig-
nificant (>60%) narrowing of the previously dilated seg-
ment. The protocol of the ergonovine test has been previously
reported (4) . The lesion s before and after angioplasty were
carefully measured with an automated digital caliper using
a 6502 microprocessor (5). For each narrowing, at least two
measurements were performed in different projections and
the result s were expressed as a mean of these two values .
Statistical analysis. All results were expressed as mean
± SD . Differences between the two groups with respect to
the frequency of an event were determined by chi-square
analy sis . Comparisons were performed between two means
using the unpaired Student's t-test. A probability (p) value
of less than 0.05 was considered statistically significant.
was not significantly different from the mean age 50 ± 9
years in the 90 men and 7 women in Group B. Symptoms
in the two groups were signific antly different (p < 0.00 I) :
group B was characterized by an important proportion of
patients with angina at rest or typic al Prinzmetal variant
angina , whereas exertional angina was the common clinical
feature observed in group A. There was also a significant
difference (p < 0.05) in the extent of coronary artery dis-
ease . In group B, 79 (81%) of 97 patients had single vessel
disease whereas 33% of patients in group A had double
(29%) or triple (4.5%) vessel disease . In patients with dy-
namic coronary stenosis (group B) the spasm involved the
left anterior descending coronary artery in 63 cases , the
right coronary artery in 22 and the left circumflex branch
in II. In one patient, spasm involved simultaneously the
left anterior descending coronary artery and the circumflex
branch . In groups A and B, 146 and 114 coronary vessels
were dilated respectively . There were no significant differ-
ences in the locations of the stenoses that were to be dilated
in both groups.
Coronary angioplasty procedure. Percutaneous trans-
luminal coronary angioplasty was performed with the method
of Gruntzig et al. (6,7). Until July 1983, we used Dilaca ' s
catheter and the subsequent cases were treated with the
steerable guide wire . The number, maximal pressure and
total duration of inflations were similar in the two group s.
Howe ver , there was a significant difference in the size of
the balloon. In group B, the vessels were dilated with a 3.7
mm balloon in 46% of the patients versus only 27% of the
patients in group A. A 3 mm balloon was most commonly
used (68% of cases) in group A but was employed in only
49% of the patients in group B.
Immediate results. The gain in luminal patency was
similar in groups A and B (48.6 ± 18% in group A versus
50.8 ± 15% in group B) (p = NS). After angioplasty the
degree of residual stenosis was 23 ± 39% in group A and
21 ± 48% in group B (p = NS). The transstenotic pressure
gradient (obtained in 150 patients) was significantly and
equally reduced in both groups: from 53 ± 27 to 9 ± 10
mm Hg in group A and from 57 ± 23 to 8 ± 8 mm Hg
in group B; again there was no difference between groups
A and B.
Clinical follow-up. At the time of follow-up angiog-
raphy, 62% of patients in group A and 56% of patients in
group B were asymptomatic. In group B, II had anginal
pain at rest while 4 complained of pain during effort and at
rest ; only 4 of them had effort angina alone and 3 had
unstable angina.
Follow-up angiography. At the time of reinvestigation,
29 (22%) of the 132 patients in group A had a restenosis
defined as a loss of 50% of the initial gain. In contrast, 34
(35%) of the 97 patients in group B had restenosis, a sig-
nificantly higher rate that in group A (p < 0.05). However,
II (38%) of the 29 patients in group A with restenosis were
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Table 2. Follow-Up Data in 43 Patients With Restenosis
Discussion
Previous studies in coronary angioplasty. In 1976,
Selzer (8) discussed the concept of dynam ic coronary ste-
totall y free of symptoms; the others (62%) experienced
symptoms listed in Table 2. In group B, only 15% of patient s
with angiographi c evidence of restenosis were asymptomatic
and 85% of them had recurrence of symptoms . Thu s, the
incidence of patients with recurrence of symptoms associ-
ated with angiographic evidence of restenosis was signifi-
cantly higher in group B (dynamic coronary stenos is) than
in group A (30 versus 14%, p < 0.01).
Provocative test with ergonovine. The provocative test
was repeated during coronary angiography in 123 patients
in group A and 87 patients in group B. In the patients with
dynamic coronary stenosis (group B) coronary artery spasm
was induced in 38 (44%) . In patients with previously fixed
coronary stenos is (group A) 19 ( 15%) of 123 had coron ary
artery spasm at the time of rein vestigat ion .
Among the 29 patient s in group A with res tenos is, a
provocative test was performed in 20 and induced spasm in
8 (40%) . In 34 patients in group B with restenosis, 27
underwent an ergonovine test: 22 (81.5%) had spasm at the
site of the dilation . Thu s, for the whole group of 47 patient s
with restenosis who underwent the ergonovine test, 30 (64%)
had spasm superimposed on restenosis .
Restenosis
Asymptomatic with restenosis
Symptoms associated with restenosis
Effort angina
Angina at rest
Mixed angina
Prinzmetal variant angina
Unstable angina
Atypical chest pain
Ergonovine tests
No. of cases
Positive test
Spasm superimposed on restenosis
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nosis characterized by spasm superimposed on atheroscle-
rotic narrowing: both dynamic and fixed components could
contribute variably to the degree of obstruction. The fixed
obstru ction can be treated with coronary angioplasty. and
in 1982, David et al. (2) demonstrated that coronary an-
giopl asty was technically feasible in patients with Prinz-
metal' s variant ang ina. Howe ver , the symptoms recurred
after successful treatment with coronary angioplas ty in 5 of
13 patients and, within 4 months of the procedure, 5 of the
patients had resteno sis and 2 others developed severe lesion s
adjacent to the site of angioplasty . More recentl y , Hollman
et al. (9) reviewed the cl inical course of five patients man-
ifesting coronary spasm at the site of previous success ful
coronary angioplasty. In all five cases spasm was observed
on a hemodynamically insignificant obstruction. Four pa-
tients did not respond to therapy with a calcium antagonist
and subsequently devel oped restenosis . One patient died and
pathologic study revealed new atherosclerotic disease . Cor-
cos et al. (3) described a series of 2 1 patient s with Prinz-
metal' s variant angina treated with coronary angioplasty:
the procedure was successful in 19 but angina persisted or
recurred I to 4 month s after coronary angioplas ty in nine
patient s (47%) who had restenosis.
Present results of coronary angioplasty in patients
with variant angina. Thus, our study is the fourth report
concerning coronary angioplasty in a large series (n = 97)
of patients with coronary artery spasm superimposed on
atheroscleroti c narrowing . However , our presentation dif-
fers from the preceding studies in that spasm was demon-
strated before the procedure while it was recognized be-
foreh and in only 5 of the 15 cases of David et al. (2) . Thi s
resulted from our systematic approach and search for spasm
with provocative testing as described in 1982 (4) . Coronary
artery spasm persisted in 44% of our patients of group B
(patients with dynamic stenosis) despite treatment with a
calcium antagonist although all the patient s received nifed-
ipine , 40 to 60 mg daily. However , treatment with this drug
was discont inued 12 to 18 hours before follow-up cathe-
teriz ation .
Among patient s of group A (patients) with fixed athero -
sclerotic narrowing). 15% had spasm involving the segment
of the dilated vessel 6 to 8 month s after coronary angio-
plasty. Th is is not totally unexpected: ex perimental studies
Table 3. Clinical and Angiographic Characteristics of Patients With or Without Restenosis
Group A (n = \32) Group B (n = 97)
Without With Without
restenosis restenosis restenosis
No. of patients 103 29 63
Age (yr) ( ± SD) 52 ± 8.7 51 ± 7.7 50 :t 9.7
Duration of symptoms (mo) 5.7 ± 3.7 5.6 ± 9. 1 3.3 ± 4.3
Stenosis before PTCA (%) 71 ± 12 72 ± 11 73 ± 14
PTCA = percutaneous transluminal coronary angioplasty.
With
restenosis
34
5 1 ± S.2
4 ± 8
7 \ :t J 1
JACC Vol. 8. No. 3
September 1986:504-8
BERTRAND ET AL.
ANGIOPLASTY IN DYNAMICOR FIXED CORONARY STENOSIS
507
(10) have shown that after coronary angioplasty, the en-
dothelium is damaged and denuded, expo sing the neointima
to platelet adhesion. This could lead to the release of platelet
factors such as adenosine diphosphate (ADP). platelet growth
factor 4 and thromboxane, the latter being a potent vasocon-
strictor agent. Therefore, coronary angioplasty can exag-
gerate the vasomotor reactivity of the dilated segment, lead-
ing to residual spasm .
Restenosis after coronary angioplasty. For the total
group, the rate of restenosis (63 of 229 patients or 27.5%)
is comparable with that of other series. However, the dif-
ferences in our two group s are noteworthy; the incidence
of restenosis was higher when coronary angioplasty was
performed on a dynamic narrowing (group B) than on a
fixed atherosclerotic stenosis (group A). When restenosis
occurred, coronary artery spasm was frequently (64%) su-
perimposed on this segment.
Restenosis is a common complication of coronary an-
gioplasty and could limit the long-term benefit of this pro-
cedure . Several studies have emphasized the role of repeated
angioplasty in patients who had recurrent stenosis after the
first attempts; reliable means of preventing recurrence are
needed but the mechani sms of restenosis are still unclear.
A report from the National Heart, Lung, and Blood Insti-
tute's Percutaneous Transluminal Coronary Angioplasty re-
gistry (I) selected , with multivariate analy sis, four factors
associated with restenosi s: male sex, angioplasty of bypass
graft , severity of angina before angioplasty and no history
of prior myocardial infarction . The report (I) mentioned
that patient age , duration of symptoms before angioplasty
and severity of stenosis were important determinants of suc-
cessful coronary angioplasty . However, in our study , the
restenosis rate in the two patient groups was not affected
by these factors (Table 3).
Some reports (11,12) emphasized the role of the angio-
plasty technique (size of the balloon, pressure and inflation
time) . In our study , there was only a significant difference
between the two groups concerning the size of the balloon .
David et al. ( I I ) selected , with a stepwi se logistic regres-
sion , variant angina, severit y and the length and geometry
of the stenosis as the baseline characteristics that were the
most predictive of restenosis.
These conclusions and our findings underline the role of
spasm in the pathogenesis of restenosis . Chahine and Raiz-
ner (13) in 1977 and Marzilli et al. (14) in 1980 suggested
that recurrent vasospastic episodes in an angiographically
normal or minimally diseased coronary segment could result
in a more rapid progression of the athero sclerotic process.
Although this provocative affirmation needs confirmation ,
our results could support this hypothesis .
Clinical implications. Our study demonstrates the less
satisfactory results obtained with coronary angioplasty in
patients with dynamic coronary stenosis. More than 10 years
ago, Gaasch et al. (15) reported that the results of coronary
bypass surgery were not as good in patients with variant
angina as in patients with classical effort angina. These
results (before the era of calcium channel blockers) are
analogous to our result s. The role of drugs to prevent re-
stenosis is unclear: in our study all the patients received a
calcium antagonist, but in the study of Corcos et al. (3)
concerning coronary angioplasty in variant angina, reste-
nosis occurred only in patients not treated with calc ium
channel blockers. In contrast, a randomized study by the
same group (16) was unable to show a significant difference
in restenosis in two groups treated or not treated with cal-
cium antagonists. Faxon et al. (17) have shown that lower
recurrence rates than are recorded in control animals can be
achieved with antiplatelet drugs. Aspirin has been shown
to be at least as effective as warfarin in the treatment of
patients with recurrent stenosis, and overall the study showed
a lower incidence of recurrent stenosis among aspirin-treated
patients. Our two groups of patients received dipyridamole ,
but only a low dose was administered. Finally, these ob-
servations emphasize the need for further randomized stud-
ies to detect appropriate drug prevention of restenosi s after
successful angioplasty.
We acknowledge the secretarial assistance of Catherine Feucherolles.
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